They could do even better in a future recession as investors pour into under-appreciated defensive assets. Investors have piled into tech stocks to the point where they constitute a plurality of their portfolios, if not the large majority. When a downturn hits the market, a rotation out of tech is likely. All that excess liquidity may end up making its way to the following 3 ETFs. If you are an investor who is securing profits and is buying up dividend ETFs to weather a possible downturn instead, it's not a ...

Sector Performance - Healthcare has outperformed all other sectors since the start of September, rising 13% [2] - The State Street Health Care Select Sector SPDR ETF (XLV) leads this performance, followed by technology at 9% and utilities at 5% [2] Fund Performance - The Tema Oncology ETF (CANC) has seen a significant increase of 28% since September and is up 41% year-to-date [2] Key Holdings in Oncology - Revolution Medicines (RVMD) is the top holding in the Tema Oncology ETF, with a remarkable gain of 127% since August 11 [3] - Roche Holdings (RHHBY) is highlighted for its attractive PE ratio of 15 and a strong pipeline of cancer immunology drugs, including a recent positive trial readout in breast cancer [4][5] - Guardant Health (GH) is noted for its liquid biopsy test that can detect cancer early, particularly colorectal cancer, which is rapidly increasing among young people in the US [5][6]